Acebrochol

Acebrochol

SCHEMBL30009744

CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]4[C@@H]3C[C@@H](Br)[C@@]2(Br)C1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPC1L1 Q9UHC9 9/20 0.56
▸ USP2 O75604 3/20 0.54
▸ LMNA P02545 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ CDC25A P30304 5/20 0.54
▸ POLA1 P09884 1/20 0.54
▸ VDR P11473 1/20 0.53
▸ NPC1 O15118 1/20 0.51
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ FNTA P49354 1/20 0.47
▸ FNTB P49356 1/20 0.47
▸ INPP5D Q92835 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acebrochol SCHEMBL1006383 1.00 NPC1L1 (0.56) NPC1L1USP2LMNAMEN1TP53
Acebrochol SCHEMBL9250494 1.00 NPC1L1 (0.56) NPC1L1USP2LMNAMEN1TP53
SCHEMBL21814362 0.92 NPC1L1 (0.62) NPC1L1USP2LMNAMEN1TP53
SCHEMBL21814361 0.92 NPC1L1 (0.62) NPC1L1USP2LMNAMEN1TP53
SCHEMBL9250800 0.91 NPC1L1 (0.56) NPC1L1USP2LMNAMEN1TP53
SCHEMBL18918658 0.85 NPC1L1 (0.69) NPC1L1USP2LMNAMEN1TP53
SCHEMBL18942513 0.85 NPC1L1 (0.69) NPC1L1USP2LMNAMEN1TP53
SCHEMBL1274095 0.85 NPC1L1 (0.69) NPC1L1USP2LMNAMEN1TP53
SCHEMBL23628419 0.83 NPC1L1 (0.64) NPC1L1USP2LMNAMEN1TP53
SCHEMBL6300889 0.83 NPC1L1 (0.55) NPC1L1USP2LMNAMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115350180-A Application of tetrabromo spiro cyclohexadienyl isoxazole compound derived from sea in preparation of medicine for treating blood tumor 上海交通大学医学院附属仁济医院 2022-11-18 — — CN disclosed
Send feedback